Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes

Author(s):  Allen Loyd V Jr

Issue:  May/Jun 2022 - Volume 26, Number 3
View All Articles in Issue

Page(s):  214-217

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Page 1
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Page 2
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Page 3
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Page 4

Download in electronic PDF format for $75

Abstract:  Enteral feeding has increased in recent years along with the various methods and equipment utilized. Oftentimes, it is necessary to administer medications via enteral tubes, and care must be observed to maintain the proper flow through the tubes. This is done by proper maintenance to prevent clogging and even removing clogs if they occur. Proper choice of a vehicle to administer a drug is critical for the patient to receive the benefit of drug therapy and to properly maintain the usefulness of the enteral feeding.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, enteral feeding tubes, drug administration, tube blockage, tube patency, tube flushing, nasogastric tube, NG tube, nasoduodenal tube, nasojejunal tube, percutaneous gastrostomy tube, percutaneous jejunostomy tube, percutaneous gastrojejunostomy tube, methylcellulose vehicle, formulation

Related Categories: FORMULATIONS, GASTROENTEROLOGY, NUTRITION AND NUTRICEUTICALS, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
May/Jun 2022
Pg. 214-217

Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
de Villiers Melgardt M
, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
May/Jun 2010
Pg. 250-256

Recommendations for Compounding Medications for Feeding Tube Administration
Klang Mark
Jul/Aug 2010
Pg. 276-282

Technology Spotlight: Tube Sealers
Jones Michael
, Adams Susan
May/Jun 2003
Pg. 206-207

Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Allen Loyd V Jr
Jul/Aug 2021
Pg. 320

Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula
Allen Loyd V Jr
Jul/Aug 2000
Pg. 304

Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration
Allen Loyd V Jr
Sep/Oct 2006
Pg. 383

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal
, Rios GL Quito
Sep/Oct 2022
Pg. 358-362

Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
Jul/Aug 2011
Pg. 302-307

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
Nov/Dec 2016
Pg. 485-493

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

Omeprazole (Prilosec) in the Atypical Patient, Administration of
Kane Dana Lynn
Jan/Feb 1997
Pg. 13

Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
Sep/Oct 2015
Pg. 389-390

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
Nov/Dec 2023
Pg. 474-481

Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
May/Jun 2016
Pg. 217-222

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

Return to Top